Unofficial US drug price watchdog the Institute for Clinical and Economic Review (ICER) has published a new white paper in collaboration with researchers at NOR 11 April 2022
The European pharma industry has commissioned a report on drug affordability which highlights its message that overall expenditure on therapies has remained sta 7 April 2022
The US Food and Drug Administration is asking for a total budget of $8.4 billion for the 2023 budget, up by a third from the previous year. 30 March 2022
The Federal Government of Australia will invest A$28.1 million ($20.9 million) into a new agency for the Health Portfolio, Genomics Australia, it has been annou 22 March 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.